Eli Lilly has said it will raise the UK list price of its diabetes and obesity therapy Mounjaro for people who buy the drug ...

Precigen has won approval in the US for a first-in-class immunotherapy for recurrent respiratory papillomatosis (RRP), a rare ...

In another sign of increased regulatory scrutiny of vaccines in the US, Health and Human Services (HHS) Secretary Robert F ...

The approval of ArteraAI Prostate by the FDA as a software as a medical device (SaMD) means it can now be used at the point ...

Regulatory agencies are offering more flexibility when it comes to viral clearance strategies, but this must be aligned with ...

The executive order from President Donald Trump calls on the HHS' Office of the Assistant Secretary for Preparedness and ...

Yantai-based RemeGen said it will now move ahead with filing telitacicept with China's National Medical Products ...

“Sexuality and intimacy are important aspects of quality of life and may also reduce some of the psychosocial distress ...

Vedanta is playing catch-up with VE303, however, as a rival microbiome therapy from Seres Therapeutics, called Vowst, has ...

Confirmation of that has come in the form of an update (PDF) from the New Jersey Department of Labour and Workforce ...

The complicated legal wrangling has been brought to a close after CureVac and BioNTech settled their mRNA patent litigation ...

AstraZeneca's Fasenra has been cleared for use by the NHS in England as an add-on treatment for the rare autoimmune disease ...